Articles - 1z1r mentioned but not cited (2)
- A knowledge-guided strategy for improving the accuracy of scoring functions in binding affinity prediction. Cheng T, Liu Z, Wang R. BMC Bioinformatics 11 193 (2010)
- Prediction of ligand binding using an approach designed to accommodate diversity in protein-ligand interactions. Marsh L. PLoS One 6 e23215 (2011)
Reviews citing this publication (1)
- In search of an enzyme: the beta-secretase of Alzheimer's disease is an aspartic proteinase. Howlett DR, Simmons DL, Dingwall C, Christie G. Trends Neurosci 23 565-570 (2000)
Articles citing this publication (20)
- A new method to detect related function among proteins independent of sequence and fold homology. Schmitt S, Kuhn D, Klebe G. J Mol Biol 323 387-406 (2002)
- A new test set for validating predictions of protein-ligand interaction. Nissink JW, Murray C, Hartshorn M, Verdonk ML, Cole JC, Taylor R. Proteins 49 457-471 (2002)
- Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes. Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. Structure 10 369-381 (2002)
- How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. J Mol Biol 301 1207-1220 (2000)
- Inclusion of multiple fragment types in the site identification by ligand competitive saturation (SILCS) approach. Raman EP, Yu W, Lakkaraju SK, MacKerell AD. J Chem Inf Model 53 3384-3398 (2013)
- Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease. Prabu-Jeyabalan M, Nalivaika EA, King NM, Schiffer CA. J Virol 78 12446-12454 (2004)
- Viability of a drug-resistant human immunodeficiency virus type 1 protease variant: structural insights for better antiviral therapy. Prabu-Jeyabalan M, Nalivaika EA, King NM, Schiffer CA. J Virol 77 1306-1315 (2003)
- Conformational constraint in protein ligand design and the inconsistency of binding entropy. Udugamasooriya DG, Spaller MR. Biopolymers 89 653-667 (2008)
- A novel family of predicted retroviral-like aspartyl proteases with a possible key role in eukaryotic cell cycle control. Krylov DM, Koonin EV. Curr Biol 11 R584-7 (2001)
- Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate. Prabu-Jeyabalan M, Nalivaika EA, Romano K, Schiffer CA. J Virol 80 3607-3616 (2006)
- HIV-1 protease variants from 100-fold drug resistant clinical isolates: expression, purification, and crystallization. Vickrey JF, Logsdon BC, Proteasa G, Palmer S, Winters MA, Merigan TC, Kovari LC. Protein Expr Purif 28 165-172 (2003)
- A new structural theme in C2-symmetric HIV-1 protease inhibitors: ortho-substituted P1/P1' side chains. Wannberg J, Sabnis YA, Vrang L, Samuelsson B, Karlén A, Hallberg A, Larhed M. Bioorg Med Chem 14 5303-5315 (2006)
- Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases. Mak CC, Brik A, Lerner DL, Elder JH, Morris GM, Olson AJ, Wong CH. Bioorg Med Chem 11 2025-2040 (2003)
- Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease. Specker E, Böttcher J, Brass S, Heine A, Lilie H, Schoop A, Müller G, Griebenow N, Klebe G. ChemMedChem 1 106-117 (2006)
- Prediction and analysis of binding affinities for chemically diverse HIV-1 PR inhibitors by the modified SAFE_p approach. Arenas M, Villaverde MC, Sussman F. J Comput Chem 30 1229-1240 (2009)
- Synthesis and extended activity of triazole-containing macrocyclic protease inhibitors. Pehere AD, Pietsch M, Gütschow M, Neilsen PM, Pedersen DS, Nguyen S, Zvarec O, Sykes MJ, Callen DF, Abell AD. Chemistry 19 7975-7981 (2013)
- From Structure to Function: A New Approach to Detect Functional Similarity among Proteins Independent from Sequence and Fold Homology. Schmitt S, Hendlich M, Klebe G. Angew Chem Int Ed Engl 40 3141-3144 (2001)
- Phenanthridine derivatives as potential HIV-1 protease inhibitors. Ershov PV, Мezentsev YV, Kaluzhskiy LA, Ivanov AS. Biomed Rep 13 66 (2020)
- Expected and unexpected results from combined beta-hairpin design elements. Dhanasekaran M, Prakash O, Gong YX, Baures PW. Org Biomol Chem 2 2071-2082 (2004)
- Efficient access to peptidyl ketones and peptidyl diketones via C-alkylations and C-acylations of polymer-supported phosphorus ylides followed by hydrolytic and/or oxidative cleavage. El-Dahshan A, Ahsanullah, Rademann J. Biopolymers 94 220-228 (2010)